Carl Zeiss Meditec (ETR:AFX) has been assigned an average rating of “Hold” from the ten ratings firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is €55.44 ($64.47).
A number of brokerages have recently issued reports on AFX. Berenberg Bank set a €58.00 ($67.44) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Wednesday, June 6th. DZ Bank restated a “sell” rating on shares of Carl Zeiss Meditec in a report on Thursday, May 31st. Nord/LB set a €60.00 ($69.77) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Thursday, May 31st. HSBC set a €55.00 ($63.95) target price on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, June 1st. Finally, Hauck & Aufhaeuser set a €62.50 ($72.67) target price on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, May 11th.
Shares of Carl Zeiss Meditec traded up €0.50 ($0.58), reaching €62.05 ($72.15), during midday trading on Monday, according to Marketbeat. 33,109 shares of the stock were exchanged, compared to its average volume of 94,405. Carl Zeiss Meditec has a twelve month low of €37.53 ($43.64) and a twelve month high of €55.25 ($64.24).
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.